ZA200202937B - N-formyl peptide receptor complex with a g-protein kinase signal pathway modification agent. - Google Patents

N-formyl peptide receptor complex with a g-protein kinase signal pathway modification agent.

Info

Publication number
ZA200202937B
ZA200202937B ZA200202937A ZA200202937A ZA200202937B ZA 200202937 B ZA200202937 B ZA 200202937B ZA 200202937 A ZA200202937 A ZA 200202937A ZA 200202937 A ZA200202937 A ZA 200202937A ZA 200202937 B ZA200202937 B ZA 200202937B
Authority
ZA
South Africa
Prior art keywords
protein kinase
receptor complex
modification agent
signal pathway
peptide receptor
Prior art date
Application number
ZA200202937A
Other languages
English (en)
Inventor
James A Clagett
Craig Palmer
Original Assignee
Histatek Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Histatek Llc filed Critical Histatek Llc
Publication of ZA200202937B publication Critical patent/ZA200202937B/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10Tetrapeptides
    • C07K5/1002Tetrapeptides with the first amino acid being neutral
    • C07K5/1005Tetrapeptides with the first amino acid being neutral and aliphatic
    • C07K5/1013Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing O or S as heteroatoms, e.g. Cys, Ser
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/05Dipeptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/07Tetrapeptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/72Receptors; Cell surface antigens; Cell surface determinants for hormones
    • C07K14/723G protein coupled receptor, e.g. TSHR-thyrotropin-receptor, LH/hCG receptor, FSH receptor
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08Tripeptides
    • C07K5/0802Tripeptides with the first amino acid being neutral
    • C07K5/0804Tripeptides with the first amino acid being neutral and aliphatic
    • C07K5/081Tripeptides with the first amino acid being neutral and aliphatic the side chain containing O or S as heteroatoms, e.g. Cys, Ser

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Endocrinology (AREA)
  • Transplantation (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cell Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
ZA200202937A 1999-10-15 2002-04-15 N-formyl peptide receptor complex with a g-protein kinase signal pathway modification agent. ZA200202937B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US15967799P 1999-10-15 1999-10-15

Publications (1)

Publication Number Publication Date
ZA200202937B true ZA200202937B (en) 2003-09-23

Family

ID=22573520

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200202937A ZA200202937B (en) 1999-10-15 2002-04-15 N-formyl peptide receptor complex with a g-protein kinase signal pathway modification agent.

Country Status (16)

Country Link
EP (1) EP1222199A4 (xx)
JP (1) JP2004507441A (xx)
KR (1) KR20020057972A (xx)
CN (1) CN100497374C (xx)
AU (1) AU8014200A (xx)
BR (1) BR0014742A (xx)
CA (1) CA2387559A1 (xx)
CZ (1) CZ20021342A3 (xx)
EA (1) EA200200451A1 (xx)
HU (1) HUP0203688A2 (xx)
IL (1) IL149125A0 (xx)
MX (1) MXPA02003782A (xx)
NO (1) NO20021732L (xx)
PL (1) PL356096A1 (xx)
WO (1) WO2001029069A1 (xx)
ZA (1) ZA200202937B (xx)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1138692A1 (en) 2000-03-29 2001-10-04 Erasmus Universiteit Rotterdam Fragments of human chorionic gonadotropin (hcg) as immunoregulator
US8680059B2 (en) 1998-05-20 2014-03-25 Biotempt B.V. Oligopeptide acetate and formulations thereof
US6844315B2 (en) 1998-05-20 2005-01-18 Erasmus Universiteit Rotterdam Immunoregulator
US20030220258A1 (en) 2001-12-21 2003-11-27 Robbert Benner Treatment of ischemic events
US7358330B2 (en) 2001-03-29 2008-04-15 Biotempt B.V. Immunoregulatory compositions
EP1300418A1 (en) * 2001-10-04 2003-04-09 Erasmus Universiteit Rotterdam Gene regulation by oligopeptides
USRE43279E1 (en) 2000-03-29 2012-03-27 Biotemp B.V. Compositions capable of reducing elevated blood urea concentration
US7786084B2 (en) 2001-12-21 2010-08-31 Biotempt B.V. Treatment of burns
WO2004100978A1 (en) * 2003-05-13 2004-11-25 Medvet Science Pty. Ltd. A method of modulating cellular transmigration and agents for use therein
WO2007004869A2 (en) 2005-07-05 2007-01-11 Biotempt B.V. Treatment of tumors
EP1864692A1 (en) 2006-06-07 2007-12-12 Biotempt B.V. Use of peptides for the control of radiation injury
US20110082091A1 (en) * 2009-09-28 2011-04-07 Theramab Gmbh Method for Preclinical Testing of Immunomodulatory Drugs

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69840851D1 (de) * 1997-11-13 2009-07-09 Mowycal Lending Llc Kleine peptide und methoden zur behandlung von asthma und entzündungen

Also Published As

Publication number Publication date
EA200200451A1 (ru) 2002-10-31
PL356096A1 (en) 2004-06-14
NO20021732L (no) 2002-06-12
JP2004507441A (ja) 2004-03-11
NO20021732D0 (no) 2002-04-12
BR0014742A (pt) 2002-08-27
MXPA02003782A (es) 2002-12-13
WO2001029069A1 (en) 2001-04-26
CA2387559A1 (en) 2001-04-26
IL149125A0 (en) 2002-11-10
CN100497374C (zh) 2009-06-10
EP1222199A1 (en) 2002-07-17
EP1222199A4 (en) 2003-03-12
CN1633447A (zh) 2005-06-29
KR20020057972A (ko) 2002-07-12
AU8014200A (en) 2001-04-30
CZ20021342A3 (cs) 2003-01-15
HUP0203688A2 (hu) 2003-02-28

Similar Documents

Publication Publication Date Title
EP1104440A4 (en) A G-PROTEIN-COUPLED 7 TRANSMEMBRANE RECEPTOR
EP1229910A4 (en) integrin
EP1194151A4 (en) ANTAGONISTS OF THE INTEGRIN RECEPTORS
ZA200202937B (en) N-formyl peptide receptor complex with a g-protein kinase signal pathway modification agent.
EP1185261A4 (en) IL-8 RECEPTOR ANTAGONISTS
AU2001290772A1 (en) Alpha v integrin receptor antagonists
AU6990000A (en) Novel integrin receptor antagonists
EP1185265A4 (en) IL-8 RECEPTOR ANTAGONISTS
EP1054903A4 (en) FISHBOY, A G PROTEIN COUPLED RECEPTOR
EP1180028A4 (en) IL-8 RECEPTOR ANTAGONISTS
EP1233981A4 (en) RECEPTOR COUPLED TO A G-PROTEIN
AU2001249573A1 (en) Chemokine receptor antagonists
IL146146A0 (en) Integrin receptor antagonists
AU4511901A (en) Nonpeptide kappa opioid receptor antagonists
HUP0201302A3 (en) Il-8 receptor antagonists
AU2574801A (en) Selective iGLUR5 receptor antagonists
EP1171467A4 (en) AXOR-27, A RECEPTOR COUPLED TO A G-PROTEIN
AU6051200A (en) Il-8 receptor antagonists
AU5344799A (en) Kappa (op2) opioid receptor antagonists
AU5572500A (en) Vegf receptor antagonists
AU5912300A (en) 16405 receptor, a g-protein coupled receptor
AU5748300A (en) Il-8 receptor antagonists
AU2001272417A1 (en) G-protein coupled receptor org3.
EP1155031A4 (en) G PROTEIN TORQUE RECEPTOR, SAID AXOR-14
EP1226435A4 (en) AXOR35, G PROTEIN COUPLED RECEPTOR